MDxHealth SA (MDXH)
1.88
+0.17
(+9.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.84
-0.04
(-2.13%)
After-Hours: 20:00
MDxHealth Shareholders Equity (Quarterly): 16.99M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.99M |
| June 30, 2024 | -8.812M |
| March 31, 2024 | -0.973M |
| December 31, 2023 | 7.208M |
| September 30, 2023 | 17.84M |
| June 30, 2023 | 26.66M |
| March 31, 2023 | 37.65M |
| December 31, 2022 | 9.315M |
| September 30, 2022 | 21.48M |
| June 30, 2022 | 29.76M |
| December 31, 2021 | 46.90M |
| June 30, 2021 | 21.49M |
| June 30, 2021 | 21.49M |
| December 31, 2020 | 5.849M |
| June 30, 2020 | 20.73M |
| June 30, 2020 | 20.73M |
| December 31, 2019 | 19.72M |
| June 30, 2019 | 38.63M |
| June 30, 2019 | 38.63M |
| December 31, 2018 | 52.12M |
| June 30, 2018 | 69.65M |
| June 30, 2018 | 69.65M |
| December 31, 2017 | 43.55M |
| Date | Value |
|---|---|
| June 30, 2017 | 55.17M |
| June 30, 2017 | 55.17M |
| December 31, 2016 | 52.74M |
| June 30, 2016 | 37.44M |
| June 30, 2016 | 37.44M |
| December 31, 2015 | 44.26M |
| June 30, 2015 | 48.17M |
| June 30, 2015 | 48.17M |
| December 31, 2014 | 23.78M |
| June 30, 2014 | 16.50M |
| June 30, 2014 | 16.50M |
| December 31, 2013 | 24.54M |
| June 30, 2013 | 31.01M |
| June 30, 2013 | 31.01M |
| December 31, 2012 | 15.99M |
| June 30, 2012 | 8.966M |
| June 30, 2012 | 8.966M |
| December 31, 2011 | 14.65M |
| June 30, 2011 | 20.81M |
| December 31, 2010 | 14.26M |
| June 30, 2010 | 16.91M |
| December 31, 2009 | 26.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.812M
Minimum
Jun 2024
46.90M
Maximum
Dec 2021
18.47M
Average
20.73M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| Galapagos NV | 3.197B |
| UCB SA | 9.597B |
| Mithra Pharmaceuticals SA | -9.487M |
| Nyxoah SA | 116.95M |
| Celyad Oncology SA | 1.107M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 157.41M |
| Total Liabilities (Quarterly) | 140.41M |
| Debt to Equity Ratio | 3.022 |
| Current Ratio | 1.541 |
| Net Debt Paydown Yield | -3.16% |